The trademark application MARITIDE was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 24, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Research and development of pharmaceutical preparations
Research and development of pharmaceutical preparations in the field of metabolic diseases, namely weight management and diabetes
Medical and scientific research information in clinical trials in the field of metabolic diseases, namely weight management and diabetes
Providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of metabolic diseases, namely weight management and diabetes
Providing websites featuring medical and scientific research information about pharmaceuticals preparations in the field of metabolic diseases, namely weight management and diabetes
Providing websites that features non-downloadable computer software that enables users to access, manage, update and display electronic databases in the field of metabolic diseases, namely weight management and diabetes.